Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ingrid Binswanger to Naloxone

This is a "connection" page, showing publications Ingrid Binswanger has written about Naloxone.

 
Connection Strength
 
 
 
3.751
 
  1. Koester S, Mueller SR, Raville L, Langegger S, Binswanger IA. Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose? Int J Drug Policy. 2017 10; 48:115-124.
    View in: PubMed
    Score: 0.546
  2. Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain. J Gen Intern Med. 2017 Mar; 32(3):277-283.
    View in: PubMed
    Score: 0.520
  3. Davis CS, Burris S, Beletsky L, Binswanger I. Co-prescribing naloxone does not increase liability risk. Subst Abus. 2016 Oct-Dec; 37(4):498-500.
    View in: PubMed
    Score: 0.517
  4. Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56.
    View in: PubMed
    Score: 0.505
  5. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015 Dec; 30(12):1837-44.
    View in: PubMed
    Score: 0.488
  6. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015; 36(2):240-53.
    View in: PubMed
    Score: 0.464
  7. Wenger LD, Showalter D, Lambdin B, Leiva D, Wheeler E, Davidson PJ, Coffin PO, Binswanger IA, Kral AH. Overdose Education and Naloxone Distribution in the San Francisco County Jail. J Correct Health Care. 2019 10; 25(4):394-404.
    View in: PubMed
    Score: 0.160
  8. Peglow SL, Binswanger IA. Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists. Med Clin North Am. 2018 Jul; 102(4):621-634.
    View in: PubMed
    Score: 0.146
  9. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653.
    View in: PubMed
    Score: 0.142
  10. Binswanger IA, Gordon AJ. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. Subst Abus. 2016; 37(1):1-3.
    View in: PubMed
    Score: 0.123
  11. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70.
    View in: PubMed
    Score: 0.100
  12. Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O'Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2022; 43(1):143-151.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)